Cytosorbents Corporation
Cytosorbents Corporation（CTSO）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · CTSO · 截至 2025年9月30日
股东结构概览
50
机构持有人数
▲ 5 vs Q2
$15.42M
机构持仓总市值
▼ $5.33M vs Q2
62.79M
总流通股
freeFloat 87.74%
16.51M
13F 申报持股数
▲ 68,487 vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
CTSO 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
AVENIR CORP surgical & medical instruments & apparatus | 5.08M | 8.12% | 8.12% | $4.75B | Nov 14, 2025 | ▲ 24.3K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 2.20M | 3.52% | 3.52% | $2.06B | Nov 7, 2025 | ▲ 79.5K |
SKYLANDS CAPITAL, LLC surgical & medical instruments & apparatus | 2.13M | 3.40% | 3.40% | $1.99B | Nov 6, 2025 | ▼ 489.4K |
NEUBERGER BERMAN GROUP LLC surgical & medical instruments & apparatus | 1.60M | 2.55% | 2.55% | $1.49B | Nov 12, 2025 | ▲ 6.3K |
CM MANAGEMENT, LLC surgical & medical instruments & apparatus | 1.29M | 2.06% | 2.06% | $1.20B | Nov 13, 2025 | ▲ 38.1K |
BLACKROCK, INC. surgical & medical instruments & apparatus | 764.8K | 1.22% | 1.22% | $714.41M | Nov 12, 2025 | ▲ 19.2K |
SARGENT INVESTMENT GROUP, LLC surgical & medical instruments & apparatus | 738.7K | 1.18% | 1.18% | $690.02M | Nov 14, 2025 | ▼ 7.5K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 601.5K | 96.07% | 96.07% | $561.98M | Nov 12, 2025 | — held |
CIBC PRIVATE WEALTH GROUP, LLC surgical & medical instruments & apparatus | 172.6K | 27.58% | 27.58% | $161.27M | Nov 24, 2025 | — held |
surgical & medical instruments & apparatus | 172.6K | 27.58% | 27.58% | $161.27M | Nov 12, 2025 | NEW |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
16
增持
+401.9K 股6
新建仓
首次建仓10
减持
−546.4K 股0
清仓
完全退出净股数变化（前50家）
144.5K
+401.9K / −546.4K
净新增持仓人
+12
新建 6 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
CTSO 内幕交易记录
数据来源：SEC Form 4
1
买入笔数
0
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Chan Phillip P. Chief Executive Officer | Nov 18, 2025 | Award | 100,000 | $0.64 | $64.0K | 1.48M | Form 4 ↗ |
Chan Phillip P. Chief Executive Officer | Aug 8, 2025 | Award | 105,600 | — | — | 1.38M | Form 4 ↗ |
Chan Phillip P. Chief Executive Officer | Aug 8, 2025 | Award | 136,400 | $1.00 | $136.4K | 136.4K | Form 4 ↗ |
Jones Edward Raymond director | Aug 8, 2025 | Award | 22,000 | $1.00 | $22.0K | 22.0K | Form 4 ↗ |
BATOR MICHAEL G. director | Aug 8, 2025 | Award | 44,000 | $1.00 | $44.0K | 44.0K | Form 4 ↗ |
MARIANI PETER J Chief Financial Officer | Aug 8, 2025 | Award | 71,500 | — | — | 538.1K | Form 4 ↗ |
MARIANI PETER J Chief Financial Officer | Aug 8, 2025 | Award | 90,000 | $1.00 | $90.0K | 90.0K | Form 4 ↗ |
Kim Jiny director | Aug 8, 2025 | Award | 22,000 | $1.00 | $22.0K | 22.0K | Form 4 ↗ |
Capponi Vincent President and COO | Aug 8, 2025 | Award | 89,100 | — | — | 766.3K | Form 4 ↗ |
Capponi Vincent President and COO | Aug 8, 2025 | Award | 111,100 | $1.00 | $111.1K | 111.1K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Cytosorbents Corporation（CTSO）主要由机构投资者持有，机构持股比例约为 26.3%。公司内部人员持股约 12.26%，散户及公众持股约占剩余的 61.45%。
Cytosorbents Corporation 最大机构股东为 AVENIR CORP，截至 September 30, 2025 持有约 5.08 million 股，占总流通股的 8.12%。
目前共有 50 家机构持有 CTSO 股票，合计持仓市值约 $15,417,218，数据来源为最新 SEC 13F 申报。
常见问题
CTSO ownershipCytosorbents Corporation（CTSO）主要由机构投资者持有，机构持股约 26.3%。最大股东为 AVENIR CORP，持股比例 8.12%。内部人员持股约 12.26%。数据来源 SEC Form 13F，截至 September 30, 2025。